SCHEMBL31669409

SCHEMBL31669409

N[C@@H]1CCN(C(=O)Oc2ccc3ncccc3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ LMNA P02545 3/20 0.48
▸ MAPT P10636 6/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ TNF P01375 1/20 0.45
▸ NOD1 Q9Y239 1/20 0.45
▸ DPP4 P27487 1/20 0.44
▸ DPP8 Q6V1X1 1/20 0.44
▸ SCN9A Q15858 1/20 0.44
▸ NR2F2 P24468 2/20 0.44
▸ KDM1A O60341 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ GALR3 O60755 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ HTR3A P46098 1/20 0.42
▸ GSK3B P49841 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31669104 0.84 CHRNA3 (0.54) ALDH1A1LMNAMAPTRAB9AHTT
SCHEMBL31669173 0.78 KMT2A (0.49) ALDH1A1LMNAMAPTRAB9AKDM4E
SCHEMBL31669212 0.77 SMN1; SMN2 (0.64) LMNAMAPTRAB9AHTTSCN9A
SCHEMBL31669183 0.77 KDM4E (0.54) ALDH1A1LMNAMAPTKDM4EHTT
SCHEMBL31669322 0.76 KMT2A (0.53) LMNAMAPTRAB9AHTTSCN9A
SCHEMBL31669154 0.75 GAA (0.63) ALDH1A1LMNARAB9AKDM1ASMN1; SMN2
SCHEMBL31669268 0.74 CHRNA3 (0.43) ALDH1A1MAPTRAB9AHTTSMN1; SMN2
SCHEMBL31669470 0.74 POLB (0.48) RAB9A
SCHEMBL31669088 0.74 CHRNA3 (0.54) ALDH1A1MAPTRAB9AKDM4EHTT
SCHEMBL27750702 0.74 ALDH1A1 (0.60) ALDH1A1LMNAMAPTRAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 ALDH1A1 3864/4885LMNA 1144/4885MAPT 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback